newsfilter
← Latest News
Business Wire·

AlloVir to Participate in the SVB Securities Global Biopharma Conference

AlloVir, Inc. (NASDAQ:ALVR), a late-clinical stage, allogeneic T-cell immunotherapy company, today announced that Chief Executive Officer Diana Brainard, M.D., will participate in a fireside chat at the SVB Securities